No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs547713353 |
chr5:120344690-120344691 |
Bivalent Enhancer Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
2 |
rs566122236 |
chr5:120344743-120344744 |
Bivalent Enhancer Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs539828303 |
chr5:120344763-120344764 |
Bivalent Enhancer Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs368763826 |
chr5:120344781-120344782 |
Bivalent Enhancer Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs138430372 |
chr5:120344793-120344794 |
Bivalent Enhancer Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs570107871 |
chr5:120344885-120344886 |
Bivalent Enhancer Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs537264459 |
chr5:120344908-120344909 |
Bivalent Enhancer Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs555886875 |
chr5:120344910-120344911 |
Bivalent Enhancer Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs573997416 |
chr5:120344921-120344922 |
Bivalent Enhancer Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs541371686 |
chr5:120344943-120344944 |
Bivalent Enhancer Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs533173944 |
chr5:120344980-120344981 |
Bivalent Enhancer Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs551393298 |
chr5:120344981-120344982 |
Bivalent Enhancer Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs571739582 |
chr5:120345015-120345016 |
Bivalent Enhancer Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs149620117 |
chr5:120345052-120345053 |
Bivalent Enhancer Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs564046224 |
chr5:120345108-120345109 |
Bivalent Enhancer Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs531400874 |
chr5:120345117-120345118 |
Bivalent Enhancer Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs17147214 |
chr5:120345122-120345123 |
Bivalent Enhancer Strong transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
18 |
rs143323253 |
chr5:120345184-120345185 |
Bivalent Enhancer Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs183648201 |
chr5:120345214-120345215 |
Bivalent Enhancer Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs4895294 |
chr5:120345218-120345219 |
Bivalent Enhancer Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs188696488 |
chr5:120345239-120345240 |
Bivalent Enhancer Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs192878928 |
chr5:120345300-120345301 |
Bivalent Enhancer Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs185060972 |
chr5:120345315-120345316 |
Bivalent Enhancer Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs17147215 |
chr5:120345330-120345331 |
Bivalent Enhancer Strong transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
25 |
rs537999969 |
chr5:120345503-120345504 |
Bivalent Enhancer Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs148379151 |
chr5:120345531-120345532 |
Bivalent Enhancer Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs17147216 |
chr5:120345544-120345545 |
Bivalent Enhancer Strong transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
28 |
rs2406285 |
chr5:120345568-120345569 |
Bivalent Enhancer Strong transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
29 |
rs553770231 |
chr5:120345571-120345572 |
Bivalent Enhancer Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs567560188 |
chr5:120345595-120345596 |
Bivalent Enhancer Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs376317272 |
chr5:120345600-120345601 |
Bivalent Enhancer Strong transcription Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs571942394 |
chr5:120345720-120345721 |
Bivalent Enhancer Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs534870433 |
chr5:120345723-120345724 |
Bivalent Enhancer Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs553276702 |
chr5:120345742-120345743 |
Bivalent Enhancer Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs577885478 |
chr5:120345787-120345788 |
Bivalent Enhancer Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs142199719 |
chr5:120345810-120345811 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs557691031 |
chr5:120345855-120345856 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs575947331 |
chr5:120345907-120345908 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs543547110 |
chr5:120345912-120345913 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs187887535 |
chr5:120345913-120345914 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs371898549 |
chr5:120345935-120345936 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs56930945 |
chr5:120345946-120345947 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs67475995 |
chr5:120345954-120345955 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs13157482 |
chr5:120345959-120345960 |
Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
45 |
rs78204360 |
chr5:120345972-120345973 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs191424853 |
chr5:120346003-120346004 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs533214282 |
chr5:120346004-120346005 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs551486452 |
chr5:120346014-120346015 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs35182561 |
chr5:120346021-120346022 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs77345560 |
chr5:120346064-120346065 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|